Oxytetracycline Anhydrous + Polymyxin B

28 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Oxytetracycline AnhydrousPolymyxin B

Administration Routes

UnknownOphthalmic

Species Affected

Unknown 24

Cat 4

Most Affected Breeds

Unknown 24

Cat (other) 3

Cat (unknown) 1

Most Reported Reactions

Color, Abnormal 22

Counterfeit product 18

Suspect counterfeit product 5

Counterfeit drug administered 3

Contamination, Mold 2

Odor, Abnormal 2

Labels, Abnormal 1

Lot # and/or Expiration date incorrect 1

Underfilling, Tubes 1

Lack of efficacy (bacteria) - NOS 1

Lack of efficacy - NOS 1

Application site swelling 1

Outcome Breakdown

Ongoing

1 (25.0%)

Recovered with Sequela

1 (25.0%)

Outcome Unknown

1 (25.0%)

Recovered/Normal

1 (25.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.